Heart Failure Seminar: Focus on Ischemic and Valvular Heart Disease
Debates on Best Outcomes with Percutaneous vs Surgical Interventions
This virtual seminar will feature heart failure experts discussing percutaneous and surgical interventions. Despite the advances in medical therapy, with growing benefit from the “4 pillars” of guideline directed medical therapy (GDMT), subsets of patients derive signification improvement in outcomes utilizing advanced percutaneous and surgical interventions via improvement in coronary flow, valvular function, and pump function.
This seminar is now available OnDemand for purchase in the HFSA Learning Center.
February 2, 2023
3:00 PM - 4:30 PM ET | Virtual Livestream
Despite the advances in medical therapy, with growing benefit from the “4 pillars” of guideline directed medical therapy (GDMT), subsets of patients derive signification improvement in outcomes utilizing advanced percutaneous and surgical interventions via improvement in coronary flow, valvular function, and pump function.
Intended Audience
This program is intended for physicians, nurses, nurse practitioners, physician assistants, and advanced practice professionals that provide care to patients with heart failure.
The Heart Failure Society of America acknowledges the following for providing an unrestricted educational grant to support the Heart Failure Seminar: Focus on Ischemic and Valvular Heart Disease: Abbott, Medtronic